These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4223555)

  • 1. New drugs: the AMA and FDA roles.
    Appel JZ
    J Ark Med Soc; 1966 Jul; 63(2):67-9. PubMed ID: 4223555
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 3. Procedure for evaluation of new drugs.
    Weston JK
    J New Drugs; 1965; 5(5):294-6. PubMed ID: 5887954
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 5. Some thoughts on the generic equivalency debate.
    Berry FB
    Med Times; 1971 Sep; 99(9):199-201. PubMed ID: 5170858
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approvals. New drugs, new uses.
    Rodman MJ
    RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204
    [No Abstract]   [Full Text] [Related]  

  • 7. Two new efforts to inform patients about drugs launch a post-PPI era.
    Med World News; 1982 Sep; 23(20):8-9. PubMed ID: 11645760
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA urged to establish "provisional approval" system for new drugs.
    Odne MA; Jeffrey LP
    Hosp Formul; 1976 Jul; 11(7):346. PubMed ID: 1026691
    [No Abstract]   [Full Text] [Related]  

  • 9. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 10. AMA drug evaluations. A praiseworthy venture.
    Robinson RR; Clapp JR
    Arch Intern Med; 1971 Jul; 128(1):147-8. PubMed ID: 5088410
    [No Abstract]   [Full Text] [Related]  

  • 11. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMA-DE II.
    Ballin JC
    JAMA; 1973 Jul; 225(5):517. PubMed ID: 4740342
    [No Abstract]   [Full Text] [Related]  

  • 13. Year-end review shows 23 new drugs approved, 14 important biologic licensing actions taken by FDA.
    Clin Pharm; 1991 Mar; 10(3):167-8. PubMed ID: 2040121
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA to fast-track recombinant drugs.
    Am Pharm; 1981 Feb; NS21(2):19. PubMed ID: 7211687
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA new drug approval process.
    Gifford RW
    Conn Med; 1980 May; 44(5):309-11. PubMed ID: 7379526
    [No Abstract]   [Full Text] [Related]  

  • 16. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicine strengthens its voice at AMA annual meeting.
    Engelbrecht JA; Carpenter MS
    S D Med; 2006 Aug; 59(8):363. PubMed ID: 16941857
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA announces initiative to curb counterfeit drugs.
    FDA Consum; 2003; 37(5):6. PubMed ID: 14666893
    [No Abstract]   [Full Text] [Related]  

  • 19. Advantages of universal coding and classification system for drugs. Drug classification activities of the American Medical Association.
    Seitner PG
    Am J Hosp Pharm; 1966 Feb; 23(2):88-92. PubMed ID: 5952046
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.